University of Washington at CTAD 2026

Nov 16–19, 2026 Boston, MA ~1.7k attendees Website

University of Washington takes part in 4 sessions at CTAD 2026 in Boston. Its program spans real-world use of anti-amyloid antibodies and the infrastructure behind US Alzheimer's research centres. Its work covers long-term lecanemab persistence, a safety comparison with donanemab and brain stimulation for memory.

Organization	CTAD 2026 Attendance
University of Washington Seattle, Washington
washington.edu Universities & institutes Hosts the National Alzheimer's Coordinating Center, which pools data from US Alzheimer's Disease Research Centers.	Poster Mon Nov 16 – Tue Nov 17 2:00pm Mon – 5:30pm Tue Repeated Theta Burst Stimulation to Brain Area 8AV Transiently Improves Memory Retention in Early-Stage Alzheimer’s Disease (P038) Other mechanisms and targets Poster Thu Nov 19 7:15am–5:00pm Leveraging the NACC Data Platform and ADRC Network Infrastructure to Operationalize CLARiTI: A Model for Multimodal Data Coordination in AD/ADRD Research (P371) Real-world data and access Poster Thu Nov 19 7:15am–5:00pm Real-World Long-Term Persistence and Early Subcutaneous Maintenance Utilization of Lecanemab in the United States (P414) Anti-amyloid and anti-tau therapies · Real-world data and access Poster Thu Nov 19 7:15am–5:00pm A Safety Comparison of Lecanemab and Donanemab Across Three Clinical Institutions (P467) Anti-amyloid and anti-tau therapies · Real-world data and access

Organization

CTAD 2026 Attendance

University of Washington

Seattle, Washington

washington.edu

Universities & institutes

Hosts the National Alzheimer's Coordinating Center, which pools data from US Alzheimer's Disease Research Centers.

Poster

Mon Nov 16 – Tue Nov 17
2:00pm Mon – 5:30pm Tue

Repeated Theta Burst Stimulation to Brain Area 8AV Transiently Improves Memory Retention in Early-Stage Alzheimer’s Disease (P038)

Other mechanisms and targets

Poster

Thu Nov 19
7:15am–5:00pm

Leveraging the NACC Data Platform and ADRC Network Infrastructure to Operationalize CLARiTI: A Model for Multimodal Data Coordination in AD/ADRD Research (P371)

Real-world data and access

Poster

Thu Nov 19
7:15am–5:00pm

Real-World Long-Term Persistence and Early Subcutaneous Maintenance Utilization of Lecanemab in the United States (P414)

Anti-amyloid and anti-tau therapies · Real-world data and access

Poster

Thu Nov 19
7:15am–5:00pm

A Safety Comparison of Lecanemab and Donanemab Across Three Clinical Institutions (P467)

Anti-amyloid and anti-tau therapies · Real-world data and access

Instantly find 20 buyers from University of Washington

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction